Related Experiment Video
Updated: Feb 11, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
MiRNA-92a protects pancreatic B-cell function by targeting KLF2 in diabetes mellitus
Wenyi Wang1, Jian Wang1, Meiling Yan2
1International Medical Center, Tianjin First Central Hospital, Tianjin, China.
Aims:
diabetes mellitus is one of the most common metabolic diseases worldwide characterized by insulin resistance and pancreatic β cell dysfunction. miRNA plays an important role in DM. In previous studies, miRNA-92a could function as targets for innovative precision medicines to reduce T1D islet autoimmunity. However, the relationship between miRNA-92a and pancreatic β cell dysfunction remains unknown. The aim of the study was to investigate the role of miRNA-92a in pancreatic β cell dysfunction.
Methods:
Apoptosis, proliferation, insulin secretion and cell survival rate were detected to evaluate the function of miRNA-92a.
Results:
we found that miRNA-92a could inhibit apoptosis induced by high-glucose environment and increase the insulin secretion and proliferation. Moreover, we identify the KLF2 as direct target of miRNA-92a, suggesting that miRNA-92a may function through regulating KLF2.
Conclusion:
Altogether, we verified the function and mechanism of miRNA-92a and provide evidence that miRNA-92a may serve a potential candidate for the clinical treatment for DM.
Insights
MicroRNA-92a protects pancreatic cells from high-glucose damage, enhancing insulin secretion and proliferation. This suggests microRNA-92a is a promising therapeutic target for diabetes mellitus.
Area of Science:
- Molecular Biology
- Endocrinology
- Metabolic Diseases
Background:
- Diabetes mellitus (DM) is a global metabolic disease linked to insulin resistance and pancreatic beta cell dysfunction.
- MicroRNAs (miRNAs) are implicated in DM pathogenesis.
- The specific role of miRNA-92a in pancreatic beta cell dysfunction is not well understood.
Purpose of the Study:
- To investigate the function of miRNA-92a in pancreatic beta cell dysfunction.
- To explore the potential of miRNA-92a as a therapeutic target for DM.
Main Methods:
- Assessed apoptosis, proliferation, insulin secretion, and cell survival rates.
- Utilized cell-based assays to evaluate miRNA-92a function.
Main Results:
- miRNA-92a inhibited high-glucose-induced apoptosis.
- miRNA-92a enhanced insulin secretion and pancreatic beta cell proliferation.
- KLF2 was identified as a direct target of miRNA-92a, indicating a regulatory mechanism.
Conclusions:
- miRNA-92a plays a protective role in pancreatic beta cells against high-glucose conditions.
- The findings support miRNA-92a as a potential therapeutic candidate for clinical treatment of diabetes mellitus.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Protecting Self-Esteem

